systematic_review
    2013
    High Quality

    Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence

    Sarris J, McIntyre E, Camfield DA

    Published in CNS Drugs

    Methodology

    Systematic review of clinical studies of plant-based anxiolytics including Scutellaria species.

    Key Findings

    Evidence for skullcap consists of small short trials; kava and some other botanicals have stronger support.

    Conclusions

    Skullcap remains an under-researched anxiolytic with only preliminary clinical support.

    Limitations

    Heterogeneous preparations and outcome measures across included studies.

    Supplements Studied

    Skullcap remains an under-researched anxiolytic with only preliminary clinical support.

    Related Health Concerns

    Anxiety

    Study Details

    Year:2013
    Quality Score:7/10

    Access Study

    View on DOIView on PubMedOriginal Source

    This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.